Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Northwestern University geneticists have developed a promising new gene therapy technique that helps those who suffered from painful diabetic neuropathy (PDN).
The study, published in the journal Annals of Clinical and Translation Neurology, found that two low dose rounds of a non-viral gene therapy called VM202 greatly eased the pain in people with PDN and the relief lasted for months.
"Those who received the therapy reported more than a 50 percent reduction in their symptoms and virtually no side effects," said lead researcher Jack Kessler, a professor in the department of pharmacology at Northwestern University Feinberg School of Medicine and a physician at Northwestern Memorial Hospital. "Not only did it improve their pain, it also improved their ability to perceive a very, very light touch."
http://www.newsmax.com/Health/Health-News/gene-therapy-diabetes-neuropathy/2015/03/05/id/628524/
Sounds promising 🙂
The study, published in the journal Annals of Clinical and Translation Neurology, found that two low dose rounds of a non-viral gene therapy called VM202 greatly eased the pain in people with PDN and the relief lasted for months.
"Those who received the therapy reported more than a 50 percent reduction in their symptoms and virtually no side effects," said lead researcher Jack Kessler, a professor in the department of pharmacology at Northwestern University Feinberg School of Medicine and a physician at Northwestern Memorial Hospital. "Not only did it improve their pain, it also improved their ability to perceive a very, very light touch."
http://www.newsmax.com/Health/Health-News/gene-therapy-diabetes-neuropathy/2015/03/05/id/628524/
Sounds promising 🙂